Collegium Pharmaceutical: Starkes ADHS-Wachstum sorgt für Gewinnsprung und übertrifft Prognosen für Q1 2026
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript